Rapamycin treatment for amyotrophic lateral sclerosis Protocol for a phase II randomized, double-blind, placebo-controlled, multicenter, clinical trial (RAP-ALS trial)

RAP-ALS investigators group, RAP-ALS Investigators group, J. Mandrioli, R. D'Amico, E. Zucchi, A. Gessani, N. Fini, A. Fasano, C. Caponnetto, A. Chio, E. Dalla Bella, C. Lunetta, L. Mazzini, Kalliopi Marinou Aktipi, G. Soraru, S. De Biasi, D. Lo Tartaro, M. Pinti, A. Cossarizza

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)e11119
JournalMedicine
Publication statusPublished - 2018

Cite this